UPDATED ON: Friday, November 26, 2004
Canadian Cancer Society & NCIC:
Dr. Barbara Whylie,
Chief Executive Officer
From The Globe and Mail
Mr. René Gallant, President, Canadian Cancer Society, and Dr. Gerry Johnston, President, National Cancer Institute of Canada (NCIC), are pleased to announce the appointment of Dr. Barbara Whylie as Chief Executive Officer of the Canadian Cancer Society and the NCIC.
Dr. Whylie joined the Canadian Cancer Society and the NCIC in 1996 as Director of Cancer Control Policy. In that role, she ensured that Canadian Cancer Society health policies and information were soundly grounded in scientific evidence. She also worked closely with volunteer committees composed of healthcare and cancer control experts to advise both organizations on current and emerging healthcare and cancer control issues. From 1997 to 2002, Dr. Whylie chaired the Canadian Coalition on Cancer Surveillance, a collaboration of key national and provincial agencies with a mandate for cancer surveillance. She was also instrumental in the development of the Canadian Strategy for Cancer Control, co-chairing the initiative from 1999 to 2002. Dr. Whylie has been serving in the role of interim CEO of the Canadian Cancer Society and the NCIC since 2003. She holds a medical degree from Queen’s University in Belfast.
The Canadian Cancer Society is a national, community-based organization of volunteers whose mission is to eradicate cancer and enhance the quality of life of people living with cancer.
Funded by the Canadian Cancer Society and The Terry Fox Foundation, the National Cancer Institute of Canada is the longest-standing Canadian research organization devoted to advancing cancer control. Last year, the NCIC provided $65 million to support excellent cancer research and related programs across the country.